Showing results (81-90 of 187) with videos related to

Sort By:
Pageof 19
Arthritis and Rheumatism|January 1, 2009
Identification of relevant concepts of functioning in daily life in people with systemic lupus erythematosus: A patient Delphi exerciseBettina Bauernfeind, Martin Aringer, Birgit Prodinger, et al.
Zeitschrift Fur Rheumatologie|January 27, 2026
[Why C-reactive protein is (usually) not high in SLE]Erik Klapproth, Martyna Hempel, Nicolai Leuchten, et al.
Clinical Rheumatology|May 20, 2023
Effect of nintedanib in patients with progressive pulmonary fibrosis associated with rheumatoid arthritis: data from the INBUILD trialEric L Matteson, Martin Aringer, Gerd R Burmester, et al.
Annals of the Rheumatic Diseases|January 20, 2007
The EUSTAR model for teaching and implementing the modified Rodnan skin score in systemic sclerosisLászló Czirják, Zoltán Nagy, Martin Aringer, et al.
American Journal of Respiratory and Critical Care Medicine|June 9, 2007
Idiopathic nonspecific interstitial pneumonia: lung manifestation of undifferentiated connective tissue disease?Brent W Kinder, Harold R Collard, Laura Koth, et al.
Arthritis and Rheumatism|December 30, 2006
Effects of short-term infliximab therapy on autoantibodies in systemic lupus erythematosusMartin Aringer, Günter Steiner, Winfried B Graninger, et al.
RMD Open|December 24, 2024
Rationale for phosphodiesterase-4 inhibition as a treatment strategy for interstitial lung diseases associated with rheumatic diseasesMartin Aringer, Oliver Distler, Anna-Maria Hoffmann-Vold, et al.
Annals of the New York Academy of Sciences|July 13, 2004
Engineering anticancer T cells for extended functional longevityGraham Pawelec, Erminia Mariani, Julie McLeod, et al.
Wiener Klinische Wochenschrift|January 5, 2005
Immunoadsorption (IAS) as a rescue therapy in SLE: considerations on safety and efficacyGeorg H Stummvoll, Martin Aringer, Martin Jansen, et al.
Annals of the Rheumatic Diseases|March 12, 2018
Common language description of the term rheumatic and musculoskeletal diseases (RMDs) for use in communication with the lay public, healthcare providers and other stakeholders endorsed by the European League Against Rheumatism (EULAR) and the American College of Rheumatology (ACR)Désirée van der Heijde, David I Daikh, Neil Betteridge, et al.
Pageof 19